Draft Guidance FDA and Industry Procedures for Section 513(g) Requests for Information under the Federal Food, Drug, and Cosmetic Act

ICR 201105-0910-007

OMB: 0910-0705

Federal Form Document

Forms and Documents
Document
Name
Status
Supporting Statement A
2011-05-19
IC Document Collections
IC ID
Document
Title
Status
197892 New
ICR Details
0910-0705 201105-0910-007
Historical Active
HHS/FDA
Draft Guidance FDA and Industry Procedures for Section 513(g) Requests for Information under the Federal Food, Drug, and Cosmetic Act
New collection (Request for a new OMB Control Number)   No
Regular
Approved with change 03/13/2012
Retrieve Notice of Action (NOA) 05/26/2011
In accordance with the terms of 5 CFR 1320, OMB approves this ICR for a period of three years. If FDA requests an extension of this approval,FDA should make significant progress in making an electronic submission available. If electronic submission is not available, the agency should submit a timeline for implementation and report on progress.
  Inventory as of this Action Requested Previously Approved
03/31/2015 36 Months From Approved
114 0 0
1,368 0 0
0 0 0

This ICR collects information necessary for FDA to make a determination about the classification of devices intended for human use. Section 513 of the Federal Food, Drug, and Cosmetic Act (FD&C Act or the act) (21 U.S.C. 360c, et seq.) provides that devices classified by the regulatory controls needed to provide reasonable assurance of their safety and effectiveness. Within 60 days of the receipt of a written request for information respecting the class into which a device falls or the requirements applicable, the Secretary of Health and Human Services must provide a written statement of the classification. FDA's Center for Devices and Radiological Health (CDRH) and Center for Biologics Evaluation and Research (CBER) will use the information submitted in this ICR to provide that information.

US Code: 21 USC 360c Name of Law: Federal Food, Drug, and Cosmetic Act
  
None

Not associated with rulemaking

  75 FR 22599 04/29/2010
76 FR 30724 05/26/2011
No

1
IC Title Form No. Form Name
FD&C Act 513(g)

  Total Approved Previously Approved Change Due to New Statute Change Due to Agency Discretion Change Due to Adjustment in Estimate Change Due to Potential Violation of the PRA
Annual Number of Responses 114 0 0 114 0 0
Annual Time Burden (Hours) 1,368 0 0 1,368 0 0
Annual Cost Burden (Dollars) 0 0 0 0 0 0
Yes
Miscellaneous Actions
No
FDA is now issuing a guidance entitled "FDA and Industry Procedures for section 513(g) Requests for Information under the Federal Food, Drug, and Cosmetic Act" to assist individuals in preparing the supplemental information necessary to process the requests for a new medical device classification. FDA's Center for Devices and Radiological Health (CDRH) and Center for Biologics Evaluation and Research (CBER) will use the information submitted in a 513(g) request to provide information regarding classification information and/or regulator requirements for a single product. Parties seeking information for multiple products must submit separate 513(g) requests for each product.

$176,472
No
No
No
No
No
Uncollected
Daniel Gitteson 3017965156 [email protected]

  No

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
 
 
 
 
 
 
 
    (i) Why the information is being collected;
    (ii) Use of information;
    (iii) Burden estimate;
    (iv) Nature of response (voluntary, required for a benefit, or mandatory);
    (v) Nature and extent of confidentiality; and
    (vi) Need to display currently valid OMB control number;
 
 
 
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
05/26/2011


© 2024 OMB.report | Privacy Policy